Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening
- 1 June 2014
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 106, 53-60
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and MicePLOS ONE, 2011
- Interferon Signaling Remains Functional during Henipavirus Infection of Human Cell LinesJournal of Virology, 2011
- Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISAVirology Journal, 2010
- Development of a neutralization assay for Nipah virus using pseudotype particlesJournal of Virological Methods, 2009
- Simulating Henipavirus Multicycle Replication in a Screening Assay Leads to Identification of a Promising Candidate for TherapyJournal of Virology, 2009
- Nipah Virus Edits Its P Gene at High Frequency To Express the V and W ProteinsJournal of Virology, 2009
- Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virusJournal of Virological Methods, 2008
- Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNAVirology, 2008
- Establishment of a Nipah virus rescue systemProceedings of the National Academy of Sciences, 2006
- Poly(I)-Poly(C 12 U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus InfectionAntimicrobial Agents and Chemotherapy, 2006